Today, COTA is introducing COTA Connect: a powerful new capability to link data with a variety of different supplemental data sources, including linking COTA’s robust real-world clinical data to claims, imaging, socioeconomic data, and more.
We’re excited about COTA Connect – another step toward making it easier and more cost-effective to understand the precise mix of preventative care and treatments so that patients can live longer, healthier, and productive lives.
-Miruna Sasu at Datavant’s Future of Health Data Summit
- Analyzing costs and resource utilization: Combined data can reveal relationships between treatment selection, resource utilization, costs, and health outcomes to support quality initiatives, aid research, and develop improved standards of care.
- Understanding relationships between cancer and other healthcare issues: People with cancer often have other comorbidities that influence spending, utilization, and quality of life. The ability to explore non-oncology data elements in conjunction with oncology events can help coordinate care and highlight unintended side effects of therapies.
- Capturing additional detail for a comprehensive journey: Claims data contains a wealth of information about specialty care, referrals, prescriptions, and ED utilization that may enhance understanding of how cancer impacts costs, outcomes, and risk scores. As value-based care becomes more important in oncology, so will the ability to have a full understanding of a patient’s clinical status and utilization across the entire care continuum.
“COTA Connect is a high-value supplement to our flagship Focus and Vantage offerings,” said Sandy Leonard from COTA. “We’re excited to provide these critical additional features to make it easier and more cost-effective to access real-world data that can have a measurable impact on the work of life science companies and clinical care providers.”
